About Aetna Wun Trombley
Form D filings for Carmot Therapeutics from 2017 to 2023 list Aetna Wun Trombley as director.
Aetna Wun Trombley reports to the SEC as an officer of 1 public company: NGM Biopharmaceuticals (NGM).
Aetna Wun Trombley first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Aetna Wun Trombley in the role, so the role may have started earlier or lasted longer.
NI
NGM Biopharmaceuticals Inc.
President & COO
2019 – 2020 · Public company (NGM)
Key Colleagues at Startups
The people Aetna Wun Trombley works with at each company, as listed on that company's latest Form D.
Carmot Therapeutics Inc. · Form D, Jun 6, 2023
AD
Anne Phillips, M.D.
Director
TK
Tim Kutzkey
Director
PS
Peter Svennilson
Director
TG
Timothy Garnett
Director
SD
Stig Hansen, Ph.D.
Director
HT
Heather Turner
Chief Executive Officer and director